Business ❯ Pharmaceuticals

Corporate Strategy

Mergers and Acquisitions Workforce Management Legal Issues Cost Management Acquisitions AstraZeneca Sustainability Initiatives Novo Nordisk Job Cuts Merck Employment Investment Decisions Talent Acquisition Pricing Strategies Management Changes Competitive Analysis Divestment

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

The purchase adds a late-stage, FDA-designated flu preventive to bolster Merck’s post‑Keytruda growth.

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Molecule Discovery

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us

Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.